Want to join the conversation?
Industrial products maker $DOV reported 2Q16 net income of $118.3MM or $0.76 per diluted share, down 64.4% versus $332.4MM or $2.10 per diluted share in 2Q15, hurt by lower revenue and higher SG&A expense. Previous quarter also benefited from $176.8MM of earnings from discontinued operations. Revenue fell 4.1% to $1.7Bil in the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?